Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells
about
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsEncapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancerDocosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actionsCUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Embryonic stem cell factors and pancreatic cancerAcetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancersUse of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Riproximin's activity depends on gene expression and sensitizes PDAC cells to TRAIL.Cell cycle specific radiosensitisation by the disulfiram and copper complexOxidizing to death: disulfiram for cancer cell killing.Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs).Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells.The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis.Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice.A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy.Cisplatin resistance reversal by disulfiram and caffeine.Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation ResistanceCytokines, breast cancer stem cells (BCSCs) and chemoresistance
P2860
Q26786476-44580E5F-CE3D-4C19-9A76-71F176435C46Q30842293-9A245363-6060-4A86-AB93-E9BEBCDD0108Q33566735-F95548E8-3899-4D8A-BE4E-E6A4F3079D35Q34437996-3DE78313-D350-4431-A8B3-79F18AF3A2CFQ35113612-CE48B9CA-78CE-43C6-9A05-19FD428405D7Q35140669-69F5F627-5BC9-481D-9FC0-86BB2FF1CDBFQ38784131-513D6ED6-C362-4C2E-923F-8D4B69EFD705Q38869922-13E63419-ABE5-4672-9B0D-A6AB48C93ADDQ38985863-7327F58D-8427-4FA5-9942-AB5D5CB06F93Q42371594-CB9C3BA3-3968-484A-88C1-34DF57F68D3DQ42653777-EEB8BB04-CD32-43F4-9584-16C18D4CD832Q47117704-E052AF4D-492C-4425-8A85-EF6AD487780CQ47754576-D12FC8C9-FFB8-4A2E-90D1-7BC5857A44A0Q49581472-0B3FD243-511D-4F32-8745-B171AA1428CCQ50877858-34C21F16-0FA1-4745-A538-C3883F450DC2Q52881176-F850024F-4CA9-4569-9B85-A206677D4847Q55142407-0DDA5E99-77C2-454B-AB37-0FA8347703DEQ56761472-50708DB7-0F1A-4D95-B6F0-69BBBE4A26BFQ57106445-708745C0-929B-4BF6-9D81-DA242380FA2E
P2860
Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Reversing the intractable natu ...... therapy-resistant cancer cells
@ast
Reversing the intractable natu ...... therapy-resistant cancer cells
@en
Reversing the intractable natu ...... therapy-resistant cancer cells
@nl
type
label
Reversing the intractable natu ...... therapy-resistant cancer cells
@ast
Reversing the intractable natu ...... therapy-resistant cancer cells
@en
Reversing the intractable natu ...... therapy-resistant cancer cells
@nl
prefLabel
Reversing the intractable natu ...... therapy-resistant cancer cells
@ast
Reversing the intractable natu ...... therapy-resistant cancer cells
@en
Reversing the intractable natu ...... therapy-resistant cancer cells
@nl
P2093
P2860
P1433
P1476
Reversing the intractable natu ...... therapy-resistant cancer cells
@en
P2093
Da-Hye Lee
Gou Young Koh
Hoguen Kim
Honsoul Kim
Sang Kyum Kim
Tackhoon Kim
Tae-shin Kim
P2860
P304
P356
10.1371/JOURNAL.PONE.0078130
P407
P577
2013-01-01T00:00:00Z